Bio-Rad Laboratories EPS - Earnings per Share 2010-2023 | BIO.B

Bio-Rad Laboratories annual and quarterly earnings per share history from 2010 to 2023. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
  • Bio-Rad Laboratories EPS for the quarter ending March 31, 2023 was $2.32, a 102.06% decline year-over-year.
  • Bio-Rad Laboratories EPS for the twelve months ending March 31, 2023 was $-6.97, a 72.1% increase year-over-year.
  • Bio-Rad Laboratories 2022 annual EPS was $-121.79, a 186.48% decline from 2021.
  • Bio-Rad Laboratories 2021 annual EPS was $140.83, a 11.35% increase from 2020.
  • Bio-Rad Laboratories 2020 annual EPS was $126.47, a 117.04% increase from 2019.
Bio-Rad Laboratories Annual EPS
2022 $-121.79
2021 $140.83
2020 $126.47
2019 $58.27
2018 $12.10
2017 $4.07
2016 $0.88
2015 $3.71
2014 $3.05
2013 $2.69
2012 $5.78
2011 $6.29
2010 $6.59
2009 $5.20
Bio-Rad Laboratories Quarterly EPS
2023-03-31 $2.32
2022-12-31 $27.35
2022-09-30 $-5.52
2022-06-30 $-31.12
2022-03-31 $-112.50
2021-12-31 $-51.83
2021-09-30 $129.96
2021-06-30 $30.32
2021-03-31 $32.38
2020-12-31 $27.96
2020-09-30 $43.64
2020-06-30 $32.15
2020-03-31 $22.72
2019-12-31 $18.35
2019-09-30 $-8.68
2019-06-30 $19.86
2019-03-31 $28.74
2018-12-31 $-27.43
2018-09-30 $8.89
2018-06-30 $8.87
2018-03-31 $21.77
2017-12-31 $2.76
2017-09-30 $0.73
2017-06-30 $0.17
2017-03-31 $0.41
2016-12-31 $-0.77
2016-09-30 $0.62
2016-06-30 $0.61
2016-03-31 $0.42
2015-12-31 $1.54
2015-09-30 $0.59
2015-06-30 $0.97
2015-03-31 $0.61
2014-12-31 $1.34
2014-09-30 $0.39
2014-06-30 $1.09
2014-03-31 $0.23
2013-12-31 $1.04
2013-09-30 $-0.25
2013-06-30 $1.20
2013-03-31 $0.70
2012-12-31 $1.51
2012-09-30 $1.49
2012-06-30 $1.69
2012-03-31 $1.09
2011-12-31 $2.11
2011-09-30 $1.61
2011-06-30 $1.41
2011-03-31 $1.16
2010-12-31 $2.41
2010-09-30 $1.59
2010-06-30 $1.35
2010-03-31 $1.24
2009-12-31 $1.35
2009-09-30 $1.38
2009-06-30 $1.37
2009-03-31 $1.10
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $10.988B $2.802B
BIO-RAD LABORATORIES, INC. manufactures and supplies to life sciences research, healthcare, analytical chemistry, semiconductor and other markets a broad range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $137.942B 8.43
GSK (GSK) United Kingdom $69.839B 9.75
QIAGEN (QGEN) Netherlands $10.584B 22.35
Ginkgo Bioworks Holdings (DNA) United States $3.379B 0.00
Arcus Biosciences (RCUS) United States $1.536B 0.00
Biohaven (BHVN) United States $1.482B 0.00
Emergent Biosolutions (EBS) United States $0.416B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.191B 0.00
Enzo Biochem (ENZ) United States $0.110B 0.00
SQZ Biotechnologies (SQZ) United States $0.018B 0.00